Active trachoma is associated with increased conjunctival expression of IL17A and profibrotic cytokines

Infection and Immunity

Volumn 79, Issue 12, 2011, Pages 4977-4983

  Burton, Matthew J ^a,b   Ramadhani, Athumani ^b   Weiss, Helen A ^a   Hu, Victor ^a,b   Massae, Patrick ^b   Burr, Sarah E ^a,c   Shangali, Wahida ^d   Holland, Martin J ^a   Mabey, David C W ^a   Bailey, Robin L ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

^c MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^d Kilimanjaro Regional Eye Care Programme   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

CCL18 CHEMOKINE; CD94 ANTIGEN; CHEMOKINE; CONNECTIVE TISSUE GROWTH FACTOR; DNA; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; INTERLEUKIN 17; PSORIASIN; RNA; UNCLASSIFIED DRUG; CYTOKINE; IL17A PROTEIN, HUMAN;

ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BACTERIUM DETECTION; CELLULAR IMMUNITY; CHILD; CHLAMYDIA TRACHOMATIS; CLINICAL FEATURE; CONJUNCTIVA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA ISOLATION; FEMALE; FIBROGENESIS; FIBROSIS; HUMAN; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; PAPILLARY CONJUNCTIVITIS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SCHOOL CHILD; TANZANIA; TRACHOMA; CROSS-SECTIONAL STUDY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY;

CHILD; CHILD, PRESCHOOL; CONJUNCTIVA; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-17; MALE; TANZANIA; TRACHOMA;

EID: 84855722906     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.05718-11     Document Type: Article

References (64)

1. Abraham, D. 2008. Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc? Rheumatology (Oxford) 47(Suppl. 5):v8-v9.
2. Abtin, A., et al. 2008. Flagellin is the principal inducer of the antimicrobial peptide S100A7c (psoriasin) in human epidermal keratinocytes exposed to Escherichia coli. FASEB J. 22:2168-2176.
3. Abu El-Asrar, A. M., S. A. Al-Kharashi, L. Missotten, and K. Geboes. 2006. Expression of growth factors in the conjunctiva from patients with active trachoma. Eye (Lond.) 20:362-369.
4. Bailey, R. L., M. J. Holland, H. C. Whittle, and D. C. Mabey. 1995. Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls. Infect. Immun. 63:389-392.
5. Bailey, R. L., M. Kajbaf, H. C. Whittle, M. E. Ward, and D. C. Mabey. 1993. The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective. Epidemiol. Infect. 111:315-324.
6. Bobo, L., et al. 1996. Evidence for a predominant proinflammatory conjunctival cytokine response in individuals with trachoma. Infect. Immun. 64: 3273-3279.
7. Burton, M. J., R. L. Bailey, D. Jeffries, D. C. Mabey, and M. J. Holland. 2004. Cytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic. Infect. Immun. 72:7352-7356.
8. Burton, M. J., et al. 2003. Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages. Invest. Ophthalmol. Vis. Sci. 44:4215-4222.
9. Burton, M. J., et al. 2011. What is causing active trachoma? The role of non-chlamydial bacterial pathogens in a low prevalence setting. Invest. Ophthalmol. Vis Sci. 52:6012-6017.
10. Burton, M. J., et al. 2005. A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia. Br. J. Ophthalmol. 89:1282-1288.
11. Burton, M. J., et al. 2011. Conjunctival transcriptome in scarring trachoma. Infect. Immun. 79:499-511.
12. Chang, Y., et al. 2010. The chemokine CCL18 generates adaptive regulatory T cells from memory CD4+ T cells of healthy but not allergic subjects. FASEB J. 24:5063-5072.
13. Chen, X. M., W. Qi, and C. A. Pollock. 2009. CTGF and chronic kidney fibrosis. Front. Biosci. (Schol. Ed.) 1:132-141.
14. Darville, T., and T. J. Hiltke. 2010. Pathogenesis of genital tract disease due to Chlamydia trachomatis. J. Infect. Dis. 201(Suppl. 2):S114-S125.
15. Dawson, C. R., B. R. Jones, and M. L. Tarizzo. 1981. Guide to trachoma control. World Health Organization, Geneva, Switzerland.
16. Dawson, C. R., R. Marx, T. Daghfous, R. Juster, and J. Schachter. 1990. What clinical signs are critical in evaluating the intervention in trachoma?, p. 271-278. In W. R. Bowie (ed.), Chlamydial infections. Cambridge University Press, Cambridge, United Kingdom.
17. Eckert, R. L., et al. 2004. S100 proteins in the epidermis. J. Investig. Dermatol. 123:23-33.
18. Garreis, F., et al. 6 May 2011. Expression and regulation of antimicrobial peptide psoriasin (S100A7) at the ocular surface and in the lacrimal apparatus. Invest. Ophthalmol. Vis. Sci. [Epub ahead of print.] doi:10.1167/ iovs.10-6598.
19. Ghaem-Maghami, S., et al. 1997. Characterization of B-cell responses to Chlamydia trachomatis antigens in humans with trachoma. Infect. Immun. 65:4958-4964.
20. Glaser, R., et al. 2005. Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat. Immunol. 6:57-64.
21. Gressner, O. A., and A. M. Gressner. 2008. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int. 28:1065-1079.
22. Guilloteau, K., et al. 2010. Skin inflammation induced by the synergistic action of IL-17A, IL-22, oncostatin M, IL-1α and TNF-α recapitulates some features of psoriasis. J. Immunol. 184:5263-5270.
23. Holland, M. J., et al. 1996. T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin. Exp. Immunol. 105:429-435.
24. Holland, M. J., et al. 2010. Pathway-focused arrays reveal increased matrix metalloproteinase-7 (matrilysin) transcription in trachomatous trichiasis. Invest. Ophthalmol. Vis. Sci. 51:3893-3902.
25. Hu, V. H., et al. 2011. Bacterial infection in scarring trachoma. Invest. Ophthalmol. Vis. Sci. 52:2181-2186.
26. Jeyaseelan, S., et al. 2005. Induction of CXCL5 during inflammation in the rodent lung involves activation of alveolar epithelium. Am. J. Respir. Cell Mol. Biol. 32:531-539.
27. Jinquan, T., et al. 1996. Psoriasin: a novel chemotactic protein. J. Investig. Dermatol. 107:5-10.
28. Keenan, J. D., et al. 2010. Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma. Am. J. Trop. Med. Hyg. 82:482-487.
29. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
30. Madsen, P., et al. 1991. Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin"that is highly up-regulated in psoriatic skin. J. Investig. Dermatol. 97:701-712.
31. Mathai, S. K., et al. 2010. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest. 90:812-823.
32. Meyer-Hoffert, U., et al. 2011. Flagellin delivery by Pseudomonas aeruginosa rhamnolipids induces the antimicrobial protein psoriasin in human skin. PLoS One 6:e16433.
33. Michalek, M., et al. 2009. The human antimicrobial protein psoriasin acts by permeabilization of bacterial membranes. Dev. Comp. Immunol. 33:740-746.
34. Mori, T., et al. 1999. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: a mouse fibrosis model. J. Cell. Physiol. 181:153-159.
35. Natividad, A., et al. 2010. Human conjunctival transcriptome analysis reveals the prominence of innate defense in Chlamydia trachomatis infection. Infect. Immun. 78:4895-4911.
36. Nedeau, A. E., et al. 2008. A CXCL5- and bFGF-dependent effect of PDGFB-activated fibroblasts in promoting trafficking and differentiation of bone marrow-derived mesenchymal stem cells. Exp. Cell Res. 314:2176-2186.
37. Onishi, R. M., and S. L. Gaffen. 2010. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 129:311-321.
38. Phanish, M. K., S. K. Winn, and M. E. Dockrell. 2010. Connective tissue growth factor (CTGF, CCN2)-a marker, mediator and therapeutic target for renal fibrosis. Nephron Exp. Nephrol. 114:e83-e92.
39. Prasse, A., et al. 2006. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am. J. Respir. Crit. Care Med. 173:781-792.
40. Prasse, A., et al. 2007. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Arthritis Rheum. 56:1685-1693.
41. Prasse, A., et al. 2009. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 179:717-723.
42. Prokop, S., F. L. Heppner, H. H. Goebel, and W. Stenzel. 2011. M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis. Am. J. Pathol. 178:1279-1286.
43. Ramsey, K. H., and R. G. Rank. 1991. Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines. Infect. Immun. 59:925-931.
44. Rank, R. G., and J. A. Whittum-Hudson. 2010. Protective immunity to chlamydial genital infection: evidence from animal studies. J. Infect. Dis. 201(Suppl. 2):S168-S177.
45. Rasmussen, S. J., et al. 1997. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J. Clin. Invest. 99:77-87.
46. Reynolds, J. M., P. Angkasekwinai, and C. Dong. 2010. IL-17 family member cytokines: regulation and function in innate immunity. Cytokine Growth Factor Rev. 21:413-423.
47. Saw, V. P., et al. 2009. Conjunctival interleukin-13 expression in mucous membrane pemphigoid and functional effects of interleukin-13 on conjunctival fibroblasts in vitro. Am. J. Pathol. 175:2406-2415.
48. Skwor, T. A., et al. 2008. Role of secreted conjunctival mucosal cytokine and chemokine proteins in different stages of trachomatous disease. PLoS Negl. Trop. Dis. 2:e264.
49. Stephens, R. S. 2003. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol. 11:44-51.
50. Taylor, H. R., S. L. Johnson, J. Schachter, H. D. Caldwell, and R. A. Prendergast. 1987. Pathogenesis of trachoma: the stimulus for inflammation. J. Immunol. 138:3023-3027.
51. Thylefors, B., C. R. Dawson, B. R. Jones, S. K. West, and H. R. Taylor. 1987. A simple system for the assessment of trachoma and its complications. Bull. World Health Organ. 65:477-483.
52. Torrado, E., and A. M. Cooper. 2010. IL-17 and Th17 cells in tuberculosis. Cytokine Growth Factor Rev. 21:455-462.
53. Van Voorhis, W. C., L. K. Barrett, Y. T. Sweeney, C. C. Kuo, and D. L. Patton. 1997. Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. Infect. Immun. 65:2175-2182.
54. Verdoni, A. M., R. S. Smith, A. Ikeda, and S. Ikeda. 2008. Defects in actin dynamics lead to an autoinflammatory condition through the upregulation of CXCL5. PLoS One 3:e2701.
55. Wang, Q., et al. 2011. Cooperative interaction of CTGF and TGF-beta in animal models of fibrotic disease. Fibrogenesis Tissue Repair 4:4.
56. West, N. R., and P. H. Watson. 2010. S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer. Oncogene 29:2083-2092.
57. West, S. K., B. Munoz, H. Mkocha, Y. H. Hsieh, and M. C. Lynch. 2001. Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiol. 8:137-144.
58. Wolf, R., et al. 2010. Gene from a psoriasis susceptibility locus primes the skin for inflammation. Sci. Transl. Med. 2:61ra90.
59. Wolle, M. A., B. E. Munoz, H. Mkocha, and S. K. West. 2009. Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania. Ophthalmology 116:243-247.
60. Wright, H. R., and H. R. Taylor. 2005. Clinical examination and laboratory tests for estimation of trachoma prevalence in a remote setting: what are they really telling us? Lancet Infect. Dis. 5:313-320.
61. Wynn, T. A. 2004. Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat. Rev. Immunol. 4:583-594.
62. Wynn, T. A., and L. Barron. 2010. Macrophages: master regulators of inflammation and fibrosis. Semin. Liver Dis. 30:245-257.
63. Wyrick, P. B., S. T. Knight, T. R. Paul, R. G. Rank, and C. S. Barbier. 1999. Persistent chlamydial envelope antigens in antibiotic-exposed infected cells trigger neutrophil chemotaxis. J. Infect. Dis. 179:954-966.
64. Zheng, Y., et al. 2008. Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation. Immunology 124:357-367.